VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹233 Cr | ₹261 Cr | ₹280 Cr | ₹240 Cr | ₹185 Cr |
What is the latest Net Current Assets ratio of VENUS REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹233 Cr |
| Mar2025 | ₹261 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹185 Cr |
How is Net Current Assets of VENUS REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹233 Cr | -10.43 | |
| Mar2025 | ₹261 Cr | -6.95 | |
| Mar2024 | ₹280 Cr | 16.58 | |
| Mar2023 | ₹240 Cr | 29.66 | |
| Mar2022 | ₹185 Cr | - | |
Compare Net Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,145.7 Cr | -0.8% | 0.4% | 245.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,180.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,302.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,623.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,741.0 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -0.8% |
0.4% |
245.4% |
| SENSEX | -0.9% |
-1.5% |
-5.8% |
You may also like the below Video Courses